| Literature DB >> 26695176 |
Arlette E Hesselink1, Guy E H Rutten2, Sander M Slootmaker3, Inge de Weerdt3, Lieke G M Raaijmakers4, Ruud Jonkers5, Marloes K Martens5, Henk J G Bilo6.
Abstract
BACKGROUND: The worldwide epidemic of type 2 diabetes (T2DM) underlines the need for diabetes prevention strategies. In this study the feasibility and effectiveness of a nurse led lifestyle program for subjects with impaired fasting glucose (IFG) is assessed.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26695176 PMCID: PMC4688978 DOI: 10.1186/s12875-015-0394-7
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Fig. 1Counselling schedule (second section of the RM protocol)
Fig. 2Participant flow chart and intervention compliance
Baseline characteristics, patients with at least one follow-up measurement
| Intervention group N = 171 % or mean (s.d.) | Usual care group N = 129 % or mean (s.d.) | |
|---|---|---|
| Gender | ||
| Male | 53.2 | 53.5 |
| Age (range) | 62.4 (9.8)* | 65.1 (9.7)* |
| Education | ||
| ≤ Primary education | 10.9 | 18.9 |
| Secondary school | 45.5 | 45.1 |
| Selective secondary | 26.1 | 18.0 |
| Higher | 17.6 | 18.0 |
| Smoking | ||
| Current | 14.5 | 14.8 |
| Former | 54.2 | 50.8 |
| Never | 31.3 | 34.4 |
| Motivateda | ||
| To a very high degree | 45.5 | 30.1* |
| Not at all to a high degree | 54.5 | 69.9 |
| Family history of diabetes | ||
| Direct familyb | 43.7 | 43.3 |
| Hypertension | 48.0 | 43.4 |
*Significant difference between the intervention and control groups (p ≤ 0.05)
a‘The cut-off point was pragmatically chosen, based on the number of patients per category’
bFather, mother, brother or sister
Changes in anthropometric and biochemical outcome measures
| T0 | Change | score | Univariate T1 β (95 % BI) | analysesa T2 β (95 % BI) | MLwinb T1 and T2 β (95 % BI) | |
|---|---|---|---|---|---|---|
| BMI (kg/m2) | ||||||
| IG (N = 168–155) | 29.5 (4.8) | −0.7 (4.7) | −0.6 (4.9) | −0.16 (−0.54;0.23) | −0.98 (−2.23;0.28) | −0.21 (−0.68;0.26) |
| UCG (N = 117–111) | 30.3 (5.1) | −0.8 (4.9) | −0.3 (5.3) | |||
| Weight (kg) | ||||||
| IG (N = 168–155) | 88.4 (15.9) | −1.8 (16.2) | −1.4 (16.0) | −0.28 (−1.43;0.87) | −0.46 (−1.86;0.94) | −0.48 (−1.95;1.02) |
| UCG (N = 118–112) | 90.3 (18.2) | −2.5 (18.1) | −1.1 (18.3) | |||
| Waist circumference (cm)c | ||||||
| IG (N = 165–157) | 104.0 (11.7) | −2.3 (12.2) | −2.1 (12.5) | 0.12 (−1.41;1.64) | −0.94 (−2.64;0.97) | −0.44 (−0.89;1.17) |
| UCG (N = 98–89) | 104.3 (12.9) | −3.8 (13.1) | −2.2 (13.5) | |||
| Blood glucose (mmol/L) | ||||||
| IG (N = 171–154) | 6.40 (0.34) | −0.23 (0.65) | −0.18 (0.68) | 0.09 (−0.05; 0.24) | 0.10 (−0.06;0.26) | 0.05 (−0.11;0.20) |
| UCG (N = 118–111) | 6.34 (0.46) | −0.24(0.59) | −0.25(0.62) | |||
| Systolic blood pressure (mmHg) | ||||||
| IG (N = 169–154) | 140.3 (18.0) | −3.2 (14.7) | −5.4 (16.4) | −2.45 (−5.86; 0.95) | 0.67 (−2.80;4.15) | −1.39 (−4.46;1.69) |
| UCG (N = 119–111) | 141.1 (15.1) | −1.1 (14.9) | −3.1 (17.5) | |||
| Total cholesterol (mmol/L) | ||||||
| IG (N = 167–153) | 5.18 (1.10) | −0.03 (1.07) | −0.12 (1.04) | −0.05 (−0.25;0.16) | −0.10 (−0.33;0.13) | −0.12 (−0.34;0.11) |
| UCG (N = 114–109) | 5.20 (1.10) | +0.02 (1.10) | −0.03 (1.13) | |||
| HDL cholesterol (mmol/L) | ||||||
| IG (N = 167–152) | 1.31 (0.31) | +0.05 (0.37) | +0.07 (0.40) | −0.04 (−0.09;0.01) | −0.01 (−0.04;0.07) | −0.03 (−0.10;0.05) |
| UCG (N = 115–109) | 1.27 (0.31) | +0.11 (0.37) | +0.05 (0.34) | |||
| Triglycerides (mmol/L) | ||||||
| IG (N = 166–152) | 1.64 (0.83) | −0.05 (0.97) | −0.013 (0.85) | −0.03 (−0.20;0.14) | −0.12 (−0.30;0.06) | −0.07 (−0.25;0.11) |
| UCG (N = 115–108) | 1.76 (0.96) | −0.05 (0.98) | −0.04 (1.06) | |||
β Beta, OR odds ratio, CI confidence interval, IG intervention group, UCG usual care group
aUnivariate analyses corrected for motivation and age, both on a continuous scale, and the baseline measurement
bMultilevel analyses corrected for motivation and age, both on a continuous scale, and the baseline measurement
cNo data was available on waist circumference of 15 % of the participants because these patients refused this measurement
Changes in physical activity, total and saturated fat intake and motivation
| T0 Mean (sd) or % | Change T1-T0 Mean (sd) or % | score T2-T0 Mean (sd) or % | Univariate T1 β (95 % BI) or OR (95 % BI) | Analysesa T2 β (95 % BI) or OR (95 % BI) | MLwinb T1 and T2 β (95 % BI) or OR (95 % BI) | |
|---|---|---|---|---|---|---|
| Meets standard physical activity norm (yes)c | ||||||
| IG (N = 166–142) | 65.1 | +12.1 | +12.4 | 3.53 (1.69;7.37)** | 1.22 (0.62;2.42) | 1.97 (1.22;3.20)* |
| UCG (N = 125–116) | 64.0 | +4.3 | +9.3 | |||
| Total fat intaked | ||||||
| IG (N = 168–144) | 18.2 (5.9) | −2.6 (5.5) | −2.8 (5.4) | −0.27 (−1.27;0.73) | −0.14 (−1.17;0.89) | −0.33 (−1.27;0.62) |
| UCG (N = 127–118) | 18.3 (5.5) | −2.0 (5.2) | −2.6 (5.1) | |||
| Saturated fat intake (high score)d | ||||||
| IG (N = 168–144) | 67.3 | - 3.7 | −6.9 | 1.64 (0.90;2,98) | 1.42 (0.76;2.66) | 1.61 (1.05;2.47) |
| UCG (N = 127–118) | 70.1 | −13.3 | −13.3 | |||
p-value: *P < 0.05, ** < 0.01; β Beta, OR odds ratio, CI confidence interval, IG intervention group, UCG usual care group
aUnivariate analyses corrected for motivation and age, both on a continuous scale, and the baseline measurement
bMultilevel analyses corrected for motivation and age, both on a continuous scale, and the baseline measurement
cPercentages shows the number of participants meeting the Dutch Physical Activity Norm20
dA high score on fat intake is negative.
Mean number of consultations in the IG and UCG
| Number of consultations | IG | UCG | ||
|---|---|---|---|---|
| N | (%) | N | (%) | |
| during the trial | ||||
| 3 or less | 33 | (19.5) | 44 | (34.1)** |
| 4 | 48 | (28.4) | 18 | (14.0) |
| 5 or more | 88 | (52.1) | 67 | (51.9) |
| N | 169a | 129 | ||
| in the year of follow-up | ||||
| 0 | 9 | (5.7) | 8 | (6.8) |
| 1 | 27 | (17.2) | 21 | (17.8) |
| 2–3 | 71 | (45.3) | 43 | (35.9) |
| 4 or more | 50 | (31.8) | 46 | (39.0) |
| N | 157 | 118 | ||
p-value: ** < 0.01;
aThe number of consultations is lacking for two participants